Skip to main content
Log in

A First Approach to the Study of Calixarene Solid Lipid Nanoparticle (SLN) Toxicity

Journal of inclusion phenomena and macrocyclic chemistry Aims and scope Submit manuscript

Abstract

The haemolytic effects of a series of amphiphilic calix-arene derived Solid LipidNanoparticles (SLNs) have been measured on human erythrocytes. The effectsof both the hydrophobic chain length and the nature of the polar head-groups on theamphiphilic calix[4]arene have been investigated. For all systems, no haemolyticeffects are observed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. C.D. Gutsche: Calixarenes, The Royal Society of Chemistry, Cambridge (1989).

    Google Scholar 

  2. J. Szetjli: Cyclodextrin Technology, Kluwer Academic Press, Dordrecht (1988).

    Google Scholar 

  3. G.W. Gokel: Crown Ethers and Cryptands, The Royal Society of Chemistry, Cambridge (1991).

    Google Scholar 

  4. P.D. Hart, J.A. Armstrong, and E. Brodaty: Infect. Immun. 64, 1491 (1996).

    Google Scholar 

  5. E. Aubert-Foucher, D.J.S. Hulmes, and A.W. Coleman, PCT-Int WO 0007585 (2001).

  6. G. Droogmans, J. Prenen, J. Eggermont, and T. Voets: Am. J. Physiol. 275, 646 (1998).

    Google Scholar 

  7. K.M. Hwang, Y.M. Qi, S.Y. Liu, T.C. Lee, and W. Choy: J. Chen 9403165 (1994).

  8. Y. Hamuro, M.C. Calama, H.S. Park, and A.D. Hamilton: Angew. Chem., Int. Ed. 36, 2680 (1997).

    Google Scholar 

  9. J. de Mendoza, F. Cuevas, P. Prados, E.S. Meadows, and G.W. Gokel: Angew. Chem., Int. Ed. 37, 1534 (1998).

    Google Scholar 

  10. Y. Tanaka, Y. Kobuke, and M. Sokabe: Angew. Chem., Int. Ed. 34, 693 (1995).

    Google Scholar 

  11. P. Shahgaldian, M. Cesario, P. Goreloff, and A.W. Coleman: J. Chem. Soc., Chem. Commun. 326 (2002).

  12. E. Houel, A. Lazar, E. Da Silva, A.W. Coleman, A. Solovyov, and S. Cherenok, and V.I. Kalchenko: Langmuir 18, 1374 (2002).

    Google Scholar 

  13. D. Duchêne, G. Ponchel, and D. Wouessidjewe: Adv. Drug Deliv. Rev. 36, 29 (1999).

    Google Scholar 

  14. T. Irie, M. Otagiri, M. Sunada, K. Uekama, Y. Ohtani, Y. Yamada, and Y. Sugiyama: J. Pharm. Dyn. 5, 741. FIELD Reference Number: FIELD Journal Code:7901854 FIELD Call Number: (1982).

    Google Scholar 

  15. E. Albers and B.W. Muller: J. Pharm. Sci. 81, 756 (1992).

    Google Scholar 

  16. F. Fauvelle, J.C. Debouzy, S. Crouzy, M. Goeschl, and Y. Chapron: J. Pharm. Sci. 86, 935 (1997).

    Google Scholar 

  17. J.C. Debouzy, F. Fauvelle, S. Crouzy, Y. Chapron, M. Goschl, and A. Gadelle: J. Pharm. Sci. 87, 59 (1998).

    Google Scholar 

  18. E. Leray, F. Leroy-Lechat, H. Parrot-Lopez, and D. Duchene: Supramol. Chem. 5, 149 (1995).

    Google Scholar 

  19. M. Bost, V. Laine, F. Pilard, A. Gadelle, J. Defaye, and B. Perly: J. Inclusion Phenom. Mol. Recogn. Chem. 29, 57 (1997).

    Google Scholar 

  20. M.H.B.G. Gansey, A.S. De Haan, E.S. Bos, W. Verboom, and D.N. Reinhoudt: Bioconjugate Chem. 10, 613 (1999).

    Google Scholar 

  21. M.H. Paclet, F. Morel, P. Shahgaldian, and A.W. Coleman: Unpublished results.

  22. J. Gualbert, P. Shahgaldian, and A.W. Coleman: Int. J. Pharm. 257, 69 (2003).

    Google Scholar 

  23. P. Shahgaldian, J. Gualbert, and A.W. Coleman: J. Supramol. Chem. 2, 459 (2002).

    Google Scholar 

  24. P. Shahgaldian, A.W. Coleman, and V.I. Kalchenko: Tetrahedron Lett. 42, 577 (2001).

    Google Scholar 

  25. P. Shahgaldian, E. Da Silva, A.W. Coleman, B. Rather, and M.J. Zaworotko: Int. J. Pharm. 253, 23 (2003).

    Google Scholar 

  26. P. Shahgaldian and A.W. Coleman: Langmuir 19, 5261 (2003).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shahgaldian, P., Da Silva, E. & Coleman, A.W. A First Approach to the Study of Calixarene Solid Lipid Nanoparticle (SLN) Toxicity. Journal of Inclusion Phenomena 46, 175–177 (2003). https://doi.org/10.1023/A:1026301906487

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026301906487

Navigation